Skip to content
Clinical Trials – home

Permethrin: A Comprehensive Guide for Patients

2 / 2
trials open to patients / all trials
1+
Countries

In short

This article explores the use of permethrin, a topical medication, in clinical trials for the treatment of scabies. Scabies is a contagious skin condition caused by tiny mites that burrow into the skin. The trials aim to assess the effectiveness and safety of permethrin compared to other treatments, as well as evaluate different application regimens and concentrations of permethrin cream.

At a glance

Treatment
Permethrin cream/lotion 5% or 10%
Condition
Scabies
Application
Topical, applied to whole body below neck
Duration
Usually left on for 8-14 hours before rinsing
Frequency
Typically 1-2 applications, 7-14 days apart (varies by study)
Efficacy Measures
Clinical cure, parasitological cure, reduction in pruritus
Safety Assessment
Monitoring for adverse events, skin reactions
Comparators
Ivermectin, sulfur ointment, different permethrin regimens
Patient Groups
Adults, children (2 months and older), close contacts
Study Designs
Randomized, double-blind, parallel-group trials

What is Permethrin?

Permethrin is a medication used to treat skin infestations, particularly scabies. Scabies is a condition caused by tiny mites that burrow into the skin, causing intense itching and a rash. Permethrin belongs to a class of drugs called synthetic pyrethroids, which are insecticides that can kill these mites.

Permethrin is available in various forms, including:

  • Cream (usually 5% concentration)
  • Lotion
  • Foam

Some brand names for permethrin include Elimite™, Primothrin®, Cidal®, and InfectoScab.

Uses of Permethrin

Permethrin is primarily used to treat:

  • Scabies: This is the main use of permethrin. It's considered the first-line treatment for scabies in many countries.
  • Body lice: Permethrin can also be effective against body lice infestations.

How Permethrin Works

Permethrin works by killing the mites that cause scabies. It does this by interfering with the nervous system of the mites, leading to their paralysis and death. Importantly, permethrin can kill both adult mites and their eggs, which is crucial for effective treatment.

Application Methods

The application method for permethrin can vary depending on the specific product and treatment regimen. However, some common methods include:

  • Whole-body application: The cream or lotion is usually applied to the entire body from the neck down, including under the nails. It's typically left on for 8-14 hours before being washed off.
  • Single or multiple applications: Some treatment regimens involve a single application, while others may require a second application after 7-14 days.
  • Extended application: In some cases, the medication may be applied for several consecutive days.

It's important to follow the specific instructions provided by your healthcare provider or the product label.

Effectiveness

Permethrin is generally considered highly effective for treating scabies. Clinical studies have shown that a single application of 5% permethrin cream can lead to a cure rate of around 90% in many cases.

Effectiveness is usually measured by:

  • Absence of new skin lesions
  • Healing of existing lesions
  • Improvement or disappearance of itching
  • No evidence of live mites under microscopic examination

Safety and Side Effects

Permethrin is generally considered safe for use in adults and children 2 months and older. However, like all medications, it can have side effects. Common side effects may include:

  • Stinging or burning sensation after application
  • Redness of the skin (erythema)
  • Itching
  • Rash

These side effects are usually mild and temporary. If you experience severe or persistent side effects, you should contact your healthcare provider.

Comparison with Other Treatments

While permethrin is often considered the first-line treatment for scabies, other options exist:

  • Ivermectin: This is an oral medication that can be used to treat scabies. Some studies have compared the effectiveness of oral ivermectin to topical permethrin.
  • Sulfur ointment: This is an older treatment that's still used in some cases, especially for pregnant women and young children. It's generally considered less effective and less pleasant to use than permethrin.

Special Considerations

When using permethrin, keep in mind:

  • Household treatment: To prevent reinfestation, it's often recommended that all household members be treated at the same time, even if they don't show symptoms.
  • Environmental measures: Washing clothes and bedding in hot water and vacuuming can help prevent reinfestation.
  • Persistence of symptoms: Itching may persist for a few weeks after successful treatment. This doesn't necessarily mean the treatment has failed.
  • Repeated treatment: In some cases, a second treatment may be necessary if symptoms persist or new lesions appear.

Questions people often ask

Conditions where Permethrin is being studied

Each condition opens its own overview and trial list

Trials with Permethrin

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).